RE: RE: RE: Opinion anyoneWebpilot,
Your right she stopped and Roberto sold some--but he owns tonnes so this is nothing:
BELLUS Health Inc. (BLU) | As of February 5th, 2009 |
| Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | # or value acquired or disposed of | Unit Price |
| Jan 20/09 | Dec 23/08 | Bellini, Roberto | Direct Ownership | Common Shares | 10 - Disposition in the public market | -53,700 | $0.400 |
| Jan 07/09 | Dec 30/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 7,680 | $0.340 USD |
| Jan 07/09 | Dec 29/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 17,200 | $0.340 USD |
| Jan 01/09 | Dec 31/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 10,000 | $0.450 |
| Jan 01/09 | Dec 30/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 1,500 | $0.400 |
| Jan 01/09 | Dec 30/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 10,000 | $0.420 |
| Jan 01/09 | Dec 29/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 10,500 | $0.420 |
| Jan 01/09 | Dec 29/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 32,000 | $0.400 |
| Jan 01/09 | Dec 29/08 | Bellini, Marisa | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 5,000 | $0.390 |
| Dec 30/08 | Dec 24/08 | Kruyt, Peter | Direct Ownership | Common Shares | 10 - Disposition in the public market | -2,500 | $0.415 |
 - Amended Filing |
I haven't seen the product yet--haven't really looked--though i did see a huge billboard in toronto a few weeks ago. on the plus side, I understand to difficulty with the trial--noise from a multisite trial of that magnitude may not reflect inaffectiveness of the drug. As you mention, lots of traffic to the sight so i think their are believers. Biz plan to gain traction from the NHP side to finance the drug side is smart, and the fact they lured a big guy from AG is good. Also financing doesn't seem to be an issue, so there are believers out there. Now we just need results.
Any news on the PIII trial for kiacta that they had to redo? Any other potential short-term catalysts? Otherwise this is a bottom feeder for a while.
IFC